Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"
Shuttle Pharmicals 已獲得歐洲專利號 EP3737376，標題爲 “用於治療人類疾病（包括癌症、神經系統疾病和免疫系統疾病）的選擇性組蛋白脫乙酰酶抑制劑”